Clinical Trial Update: A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating postmastectomy hypofractionation radiotherapy in high-risk breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED